Advanced search
Publication Cover
Open Access Journal of Clinical Trials Volume 2, 2010 - Issue
Submit an article Journal homepage
17
Views
0
CrossRef citations to date
0
Altmetric
Perspectives

Conducting ethical clinical trials for L. donovani in the Bihar region of India

Tiffany CrawfordGlobal Health, University of South Florida, Tampa, FL, USA
&
Brian VeselyGlobal Health, University of South Florida, Tampa, FL, USACorrespondence[email protected]
Pages 125-131 | Published online: 04 Aug 2010

References

  • Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature. 2007;5:873–882.
  • Gramiccia M, Gradoni L. The current status ofzoonotic leishmaniases and approaches to disease control. Int J Parasitol. 2005;35:1169–1180.
  • Hailu A, Gramiccia M, Kager PA. Viseral leishmaniasis in Aba-Roba, south-western Ethopia: prevalence and incidence of active and subclinical infections. Ann Trop Med Parasit. 2009;103:659–670.
  • World Health Organization. Leishmania and HIV in Gridlock. Geneva: World Health Organization; 1998:1–28.
  • Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849–854.
  • Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microb. 2004;27:305–318.
  • National Institutes of Health. Protecting Human Research Participants. DC; 2008.
  • Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland; 2002.
  • Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. New Engl J Med. 2001;345(2): 139–142.
  • Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004;189:930–937.
  • Wma.net [homepage on the Internet]. World Medical Association Declaration of Helsinki. Available from: http://www.wma.net/en/30publications/10policies/b3/index.html. Accessed Feb 20, 2010.
  • SocialMedicine.org [homepage on the Internet]. Social Medicine Portal. Available from: http://www.socialmedicine.org/2008/06/01/ethics/fda-abandons-declaration-of-helsinki-for-international-clinical-trials/. Accessed Feb 23, 2010.
  • Flory J, Emanuel E. Interventions to improve research participants’ understanding in informed consent for research: a systematic review. J Amer Med Assoc. 2004;292(13):1593–1601.
  • Indian Council of Medical Research. Ethical Guidelines for Biomedical Research on Human Participants. New Delhi; 2006.
  • Tangwa GB. Between universalism and relativism: a conceptual exploration of problems in formulating and applying international biomedical ethical guidelines. J Med Ethics. 2004;30:63–67.
  • Benatar SR, Singer PA. A new look at international research ethics. Brit Med J. 2000;321:824–826.
  • Thakur CP. Socio-economics of visceral leishmaniasis in Bihar (India). T Roy Soc Trop Med H. 2000;94:156–157.
  • Chakrabarty S, Pal M, Bharati S, Bharati P. Body form and nutritional status among adult males of different social groups in Orissa and Bihar States in India. Homo. 2008;59:235–251.
  • Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, Johnson WD Jr. Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis. 1987;156:1030–1033.
  • Sharma NL, Mahajan VK, Negi AK, Verma GK. The rK39 immuno-chromatic dipstick testing: a study for K39 seroprevalence in dogs and human leishmaniasis patients for possible animal reservoir of cutaneous and visceral leishmaniasis in endemic focus of Satluj river valley of Himachal Pradesh (India). Indian J Dermatol VE. 2009;75:52–55.
  • Parker B, Kozel V Understanding poverty and vulnerability in India’s Uttar Pradesh and Bihar: a Q-squared approach. World Dev. 2007;35: 296–311.
  • Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849–854.
  • Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. NEJM. 2010;362:504–512.
  • Rao KS. Financing of Health in India. Delhi: Institute of Economic Growth, University of Delhi Enclave; 2005:239–255.
  • Sinha PK, Ranjan A, Singh VP, et al. Visceral leishmaniasis (kala-azar) – the Bihar (India) perspective. J Infection. 2006;53:60–64.
  • Rmrims.org.in [homepage on the Internet]. Bihar: Rajendra Memorial Research Institute of Medical Sciences. Available from www.rmrims. org.in. Accessed Feb 22, 2010.
  • Dickert N, Wendler D. Ancillary care obligation of medical researchers. JAMA-J Am Med Assoc. 2009;307(4):424–428.
  • Sundar S, Jha TK, Thakur CP, et al. Oral miltefosine for Indian visceral leishmaniasis. New Engl J Med. 2002:347(22):1739–1746.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.